StonvexLoading…
StonvexStonvexStonvexCore line items from INO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $65.34K | $217.76K | $832.01K | $10.26M |
Operating Income | $-86.82M | $-112.40M | $-143.94M | $-267.57M |
Net Income | $-84.95M | $-107.25M | $-135.12M | $-279.82M |
EPS (Diluted) | $-1.81 | $-3.95 | $-6.09 | $-14.07 |
Total Assets | $74.31M | $113.20M | $170.95M | $348.53M |
Total Liabilities | $50.21M | $44.69M | $53.60M | $126.17M |
Cash & Equivalents | $44.27M | $65.81M | $14.31M | $46.33M |
Free Cash Flow OCF − CapEx | $-88.92M | $-104.56M | $-124.69M | $-217.18M |
Shares Outstanding | 69.00M | 36.10M | 22.79M | 21.09M |